Tower Research Capital LLC (Trc) Xilio Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,729 shares of XLO stock, worth $3,192. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,729
Previous 5,616
51.41%
Holding current value
$3,192
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding XLO
# of Institutions
34Shares Held
13.9MCall Options Held
0Put Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA4.57MShares$5.34 Million1.18% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD3MShares$3.51 Million0.12% of portfolio
-
River Vest Venture Management LLC St. Louis, MO1.44MShares$1.69 Million16.6% of portfolio
-
Morgan Stanley New York, NY1MShares$1.17 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA903KShares$1.06 Million0.0% of portfolio
About Xilio Therapeutics, Inc.
- Ticker XLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,471,600
- Market Cap $32.1M
- Description
- Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...